Recent data have shown that nuclear expression of PPARγ is associated with longer OS, whereas detection in the cytoplasm is a prognostically unfavorable factor in disease-free and OS in various carcinoma, including in breast cancer [46,47]. Here, PPARG is linked to breast cancer.